Takip et
Prof Dr Ibrahim Yildiz
Prof Dr Ibrahim Yildiz
Acibadem Üniversitesi Atakent Hastanesi
acibadem.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Performance status of patients is the major prognostic factor at all stages of pancreatic cancer
F Tas, F Sen, H Odabas, L Kılıc, S Keskın, I Yıldız
International journal of clinical oncology 18, 839-846, 2013
1142013
Depression, anxiety and sexual satisfaction in breast cancer patients and their partners-izmir oncology group study
A Alacacioglu, E Ulger, U Varol, I Yildiz, T Salman, V Bayoglu, A Dirican, ...
Asian Pacific Journal of Cancer Prevention 15 (24), 10631-10636, 2015
712015
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
F Tas, F Sen, S Keskin, L Kilic, I Yildiz
Molecular and clinical oncology 1 (4), 788-792, 2013
692013
Noncutaneous melanoma have distinct features from each other and cutaneous melanoma
F Tas, S Keskin, A Karadeniz, N Dağoğlu, F Sen, L Kilic, I Yildiz
Oncology 81 (5-6), 353-358, 2012
672012
Blue rubber bleb nevus syndrome associated with consumption coagulopathy: treatment with interferon
H Apak, T Celkan, A Özkan, I Yildiz, EH Aydemir, S Ozdil, S Kuruoglu
Dermatology 208 (4), 345-348, 2004
652004
SURİYELİLERİN TÜRKİYE EKONOMİSİNDE KAYIT DIŞI İSTİHDAMA ETKİLERİ VE BUNUN YANSIMASI OLARAK TÜRKİYE’YE MALİYETLERİ ÜZERİNE BİR İNCELEME
T YILDIZ, İ YILDIZ
İktisadi İdari ve Siyasal Araştırmalar Dergisi 2 (3), 30-46, 2017
602017
Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients [Izmir Oncology Group (IZOG) study]
M Akyol, E Ulger, A Alacacioglu, Y Kucukzeybek, Y Yildiz, V Bayoglu, ...
Japanese journal of clinical oncology 45 (7), 657-664, 2015
522015
Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer
F Tas, L Kilic, E Bilgin, S Keskin, F Sen, R Ciftci, I Yildiz, V Yasasever
International Journal of Gynecologic Cancer 23 (2), 2013
472013
Patterns of complementary and alternative medicine use among Turkish cancer patients
I Yildiz, M Ozguroglu, T Toptas, H Turna, F Sen, M Yildiz
Journal of palliative medicine 16 (4), 383-390, 2013
422013
The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in …
S Erdem, G Yegen, D Telci, I Yildiz, T Tefik, H Issever, I Kilicaslan, O Sanli
World journal of urology 33, 1553-1560, 2015
332015
D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients
L Kilic, I Yildiz, FK Sen, MG Erdem, M Serilmez, S Keskin, R Ciftci, ...
Cancer Biomarkers 15 (4), 405-411, 2015
312015
Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors
A Alacacioglu, E Ulger, U Varol, T Yavuzsen, M Akyol, Y Yildiz, I Yildiz, ...
Medical Oncology 31, 1-6, 2014
302014
High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer
R Ciftci, F Tas, CT Yasasever, E Aksit, S Karabulut, F Sen, S Keskin, ...
Tumor Biology 35, 6941-6948, 2014
292014
Current adjuvant treatment modalities for gastric cancer: from history to the future
L Kilic, C Ordu, I Yildiz, F Sen, S Keskin, R Ciftci, KN Pilanci
World journal of gastrointestinal oncology 8 (5), 439, 2016
282016
Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib
F Sen, I Yildiz, M Basaran, M Ekenel, F Oz, L Kilic, B Toz, A Gurdal, ...
J BUON 18 (3), 775-81, 2013
282013
Fungal peritonitis in peritoneal dialysis: a 10 year retrospective analysis in a single center.
T Basturk, Y Koc, A Unsal, E Ahbap, T Sakaci, I Yildiz, H Kayabasi, ...
European Review for Medical & Pharmacological Sciences 16 (12), 2012
282012
GLASS: Global Lorlatinib for ALK (+) and ROS1 (+) retrospective Study: real world data of 123 NSCLC patients
N Peled, R Gillis, S Kilickap, P Froesch, S Orlov, E Filippova, U Demirci, ...
Lung Cancer 148, 48-54, 2020
262020
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy
N Faruk Aykan, I Yildiz, F Sen, L Kilic, S Keskin, R Ciftci, S Karabulut, ...
Medical Oncology 30, 1-6, 2013
262013
Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers
IV Bayoglu, BB Kucukzeybek, Y Kucukzeybek, U Varol, I Yildiz, ...
Biomedicine & pharmacotherapy 70, 190-195, 2015
252015
The effects of adjuvant endocrine treatment on serum leptin, serum adiponectin and body composition in patients with breast cancer: The Izmir Oncology Group (IZOG) study
M Akyol, L Demir, A Alacacioglu, H Ellidokuz, Y Kucukzeybek, Y Yildiz, ...
Chemotherapy 61 (2), 57-64, 2016
212016
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20